These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15801271)

  • 1. Angiotropic B-cell lymphoma with telangiectasia, accompanied by panniculitic formation.
    Nishiyama H; Tanei R; Motegi T; Ohta M; Sawabe M
    J Dermatol; 2004 Dec; 31(12):1032-5. PubMed ID: 15801271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary non-Hodgkin's lymphoma presenting as a uterine cervical mass.
    Ab Hamid S; Wastie ML
    Singapore Med J; 2008 Mar; 49(3):e73-5. PubMed ID: 18362991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intravascular lymphoma: two case reports demonstrating the heterogeneity of the disease].
    Satzger I; Völker B; Kofahl-Krause D; Ganser A; Kapp A; Gutzmer R
    Hautarzt; 2009 Feb; 60(2):131-6. PubMed ID: 18654750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous panniculitic T-cell lymphoma and cytophagic histiocytic panniculitis.
    Yung A; Snow J; Jarrett P
    Australas J Dermatol; 2001 Aug; 42(3):183-7. PubMed ID: 11488712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cardiac diffuse large B-cell lymphoma with activated B-cell-like phenotype.
    Gadage V; Kembhavi S; Kumar P; Shet T
    Indian J Pathol Microbiol; 2011; 54(3):591-3. PubMed ID: 21934230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell-rich B-cell lymphoma of the spleen presenting with severe hypersplenism.
    Dincol G; Agan M; Dogan O; Diz-Kucukkaya R; Uslu B
    Clin Lab Haematol; 2006 Dec; 28(6):419-22. PubMed ID: 17105497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
    Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
    Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab plus CHOP for diffuse large-B-cell lymphoma.
    Akhtar S; Maghfoor I
    N Engl J Med; 2002 Jun; 346(23):1830-1; author reply 1830-1. PubMed ID: 12050349
    [No Abstract]   [Full Text] [Related]  

  • 9. [Angiotropic lymphoma presenting with subacute dementia: treatment with combination chemotherapy (CHOP) based on antemortem diagnosis--a case report].
    Anegawa T; Hara K; Kusaka H; Fujiyoshi K; Matsuda M
    Rinsho Shinkeigaku; 1993 Sep; 33(9):988-91. PubMed ID: 8299281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of extra-nodal lymphoma presenting as post-menopausal bleeding.
    Macnab JL; Beattie GJ; Court SJ; Davie RM; Cook MK
    J Obstet Gynaecol; 2003 May; 23(3):321-2. PubMed ID: 12918486
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute abdomen in an HIV-positive man.
    Reiter GS
    AIDS Clin Care; 1997 May; 9(5):41, 44. PubMed ID: 11364299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
    Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
    Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Standard CHOP immuno-chemotherapy for primary mediastinal lymphomas].
    Schneider T; Tóth E; Lovey J; Molnár Z; Deák B; Várady E; Csomor J; Matolcsy A; Lengyel Z; Petri K; Gaudi I; Rosta A
    Orv Hetil; 2011 May; 152(19):735-42. PubMed ID: 21498163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
    Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
    Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of primary renal lymphoma.
    Hart S; Ellimoottil C; Shafer D; Mehta V; Turk TM
    Urology; 2012 Oct; 80(4):763-5. PubMed ID: 22795375
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravascular lymphoma presenting as telangectasias: response to rituximab and combination chemotherapy.
    Weichert G; Martinka M; Rivers JK
    J Cutan Med Surg; 2003; 7(6):460-3. PubMed ID: 14605917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 61-year-old man with dyspepsia and weight loss.
    Burton C
    PLoS Med; 2005 Jun; 2(6):e154. PubMed ID: 15971937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).
    Pfreundschuh M; Schubert J; Ziepert M; Schmits R; Mohren M; Lengfelder E; Reiser M; Nickenig C; Clemens M; Peter N; Bokemeyer C; Eimermacher H; Ho A; Hoffmann M; Mertelsmann R; Trümper L; Balleisen L; Liersch R; Metzner B; Hartmann F; Glass B; Poeschel V; Schmitz N; Ruebe C; Feller AC; Loeffler M;
    Lancet Oncol; 2008 Feb; 9(2):105-16. PubMed ID: 18226581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary, highly malignant B-cell lymphoma of the prostate. Apropos of a case and review of the literature].
    Mounedji-Boudiaf L; Culine S; Devoldère G; Terrier-Lacombe MJ; Kattan J; Cazier A; Farhat F; Bekradda M; Droz JP
    Bull Cancer; 1994 Apr; 81(4):334-7. PubMed ID: 7703552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
    Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.